![]() Bicycle Therapeutics Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies. | SINOVAC SINOVAC is a biopharmaceutical company that has expertise in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. | ![]() Alumis Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies. | ![]() Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ||
Founding Date | Founding Date 1890 | Founding Date 2009 | Founding Date 2001 | Founding Date 2021 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations ID HQ | Locations Cambridge, GB HQ Cambridge, US | Locations CN HQ | Locations San Francisco, US HQ | Locations Kunming, CN HQ |
Employees | Employees 1,233 | Employees 305 | Employees 2111% decrease | Employees 107 | Employees 2,388 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) 652.3 m | Valuation ($) 3.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $72.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $24.1m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) |
Net income | Net income N/A | Net income ($219m) (FY, 2025) | Net income N/A | Net income ($243.3m) (FY, 2025) | Net income ¥125.2m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 89.4m | Total funding raised N/A | Total funding raised $ 270m | Total funding raised $ 72.8m |

Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies.
View companySINOVAC is a biopharmaceutical company that has expertise in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
View company
Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies.
View company
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company